Skip to main content

Table 1 Sociodemographic, clinical, and laboratory characteristics in 1,050 patients with clinically manifest coronary heart disease

From: Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care

Characteristics at baseline  
Age (years) (μ, SD) 58.8 ± 8.0
Men, n (%) 892 (85.0%)
CYP2C19C*2 allele frequency  
   - AA 27 (2.6%)
   - AG 279 (26.6%)
   - GG 744 (70.9%)
History of myocardial infarction, n (%) 611 (58.2%)
History of heart failure, n (%) 128 (12.6%)
Clinical score (angiographic evaluation)  
   - 1 vessel disease 255 (24.3%)
   - 2 vessel disease 279 (26.6%)
   - 3 vessel disease 449 (42.8%)
   - unknown 52 (5.0%)
School education <10 yrs., n (%) 625 (59.5%)
Body mass index (kg/m2), (μ, SD) 27.1 ± 3.5
History of diabetes, n (%) 184 (17.7%)
Total cholesterol (mg/dl) (μ, SD) 168.9 (32.6)
LDL-cholesterol (mg/dl) (μ, SD) 100.4 (28.9)
HDL-cholesterol (mg/dl) (μ, SD) 39.4 (10.5)
C-reactive protein (mg/L) * 3.47 (1.23; 8.37)
Creatinine Clearance (mL/min) * 93.75 (78.20; 115.00)
Cystatin C (mg/L)* 1.03 (0.93; 1.19)
NT-proBNP (pg/mL)* 572.00 (279.90; 1101.00)
GRACE Score (points) (μ, SD) 95.9 (20.8)
  1. * median, 25th and 75th quantile cut-point.
\